Login / Signup
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation.
Siok-Keen Tey
Steven W Lane
Published in:
Blood advances (2021)
Keyphrases
</>
stem cell transplantation
high dose
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
low dose
bone marrow